AIPOCH highlights cellular validation in AI antimicrobial discovery

Generative drug discovery is creating a massive backlog of unverified computational leads, making end-to-end evidence tracking more critical than raw screening throughput. Computational antimicrobial predictions frequently fail against complex cellular membranes or toxicity constraints without early in vitro validation. Toolkits like AIPOCH Open-Science help mitigate the reproducibility crisis by providing verifiable data provenance across modeling, testing, and review. Open, model-agnostic research workflows allow wet-lab scientists and computational biologists to maintain reproducible data lineage without lock-in.